Related content

Risk factors and prodromal markers and the development of Parkinson’s disease

By Lerche Stefanie   Seppi Klaus   Behnke Stefanie   Liepelt-Scarfone Inga   Godau Jana   Mahlknecht Philipp   Gaenslen Alexandra   Brockmann Kathrin   Srulijes Karin   Huber Heiko   Wurster Isabel   Stockner Heike   Kiechl Stefan   Willeit Johann   Gasperi Arno   Fassbender Klaus   Poewe Werner   Berg Daniela  

Journal of Neurology, Vol. 261, Iss. 1, 2014-01 ,pp. : 180-187

Springer Publishing Company

Access to resources Recommend Favorite

Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson’s disease

By Picillo Marina   Erro Roberto   Santangelo Gabriella   Pivonello Rosario   Longo Katia   Pivonello Claudia   Vitale Carmine   Amboni Marianna   Moccia Marcello   Colao Annamaria   Barone Paolo   Pellecchia Maria  

Journal of Neurology, Vol. 260, Iss. 7, 2013-07 ,pp. : 1724-1730

Springer Publishing Company

Access to resources Recommend Favorite

Tetrahydrobiopterin Availability in Parkinson’s and Alzheimer’s Disease; Potential Pathogenic Mechanisms

By Foxton Richard   Land John   Heales Simon  

Neurochemical Research, Vol. 32, Iss. 4-5, 2007-04 ,pp. : 751-756

Springer Publishing Company

Access to resources Recommend Favorite

What is known about racial disparities in Parkinson’s disease diagnosis and treatment?

By Dahodwala Nabila  

Neurodegenerative Disease Management, Vol. 3, Iss. 6, 2013-12 ,pp. : 485-487

Future Medicine

Access to resources Recommend Favorite

Olfactory loss as a supporting feature in the diagnosis of Parkinson’s disease: a pragmatic approach

By Hoyles Katie   Sharma Jagdish  

Journal of Neurology, Vol. 260, Iss. 12, 2013-12 ,pp. : 2951-2958

Springer Publishing Company

Access to resources Recommend Favorite